Back to the directory

Biocogniv

Founded
2019
Status
Acquired
Stage
Early
Team size
6
Location
Burlington, VT, USA
Category
Healthcare General
Sector
Healthcare

Federal research funding

1 NIH award totalling $299,749, FY2020.

  • Development of a Novel Diagnostic Test for Pulmonary Embolism Based on Artificial Intelligence and Spectral An

Source: NIH RePORTER.

Securities filings

1 Form D filing on record, 2023.

Filed as Biocogniv Inc.

CIK 0001997960

Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.

Company data compiled and maintained by Healthcare Discovery.